Ricardo Silva Moura
Member of the Wound Healing Innovation Research Line
Email: ricardos_moura@hotmail.com
ORCID: 0000-0002-8434-0007
Ricardo is a biologist with a Master’s degree in Biodiversity, Ecology, and Conservation. His research experience is focused on biotechnology, microbiology, and tissue bioengineering, working in graduate-level research laboratories dedicated to experimental biomedical investigation. His current scientific interests center on microbiome–host interactions and their role in chronic inflammatory diseases. During his PhD in the Medicine and Biomedical Sciences program at the University of Vic – Central University of Catalonia, he aims to investigate the mechanistic links between gut dysbiosis and respiratory diseases through the gut–lung axis using innovative microfluidic models. His research seeks to advance understanding of microbiome-driven mechanisms in human health and disease.
My last happenings:
Exploiting Hormesis for Plasma-treated Hydrogel Therapeutic platforms (HormeTic)
Subprojects: Subproject 1: "Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for cancer treatment (HormOnc)". Subproject 2: "Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for Healing of complex cutaneous wounds (HormHeal)". Original Title (English): Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for Healing of complex cutaneous wounds (HormHeal). Objective: Innovating in the healing of complex wounds. TR2Lab research team members: Albert Espona-Noguera (Principal Investigator). Cristina Canal (PI1 of Subproject 1) & Francesco Tampieri (PI2 of Subproject 1). Members of TR2Lab who participate in this project: Elisabet Sarri, Laia Bosch, Gemma Sangüesa, Francesc Sant Masoliver, Cristina Martin Mancera, David Benito Guasch, Clara Masó [...]
Lactic acid as a marker of therapeutic response
Members: Dr M. Parera (CHV), Dr I. Barba (Medicina UVic) Financial support: APR-IRIS-CC The Project “Lactic acid as a marker of therapeutic response” has received approval from the IRIS-CC ethics committee and will start recruiting patients in earnest. The project is a collaboration between Consorci Hospitalari de Vic (Dr M. Parera) and the faculty of medicine UVic (Dr I.Barba) and will evaluate lactic acid as a potential marker of therapeutic response in non-small cell lung cancer patients. We would like to thank all the patients who selflessly participate in this project. El projecte «L'àcid làctic com a [...]
Predictors of Recurrence and Survival in Endometrial Cancer: A 22-Year Single-Center Cohort Study
Funding: Industrial Doctorates Plan of the Government of Catalonia (Industrial Doctorate; DI-2024-00104) Osona Contra el Càncer (OCC) «Ajuts per a Projectes de Recerca Interns» call of the Fundació d’Estudis Superiors en Ciències de la Salut (FESS; APR-2025-FESS) Authors: E. Sardo (1,6,7,8,), M. Alejo Sánchez (2,7), M. Parera Roig (1,6,7,8,), C. Cruz Zambrano (6,7,8,), N. Espejo Herrera (2,8), K. Salas León (2), A. Canet Gómez (2), M. Armengou Ríos (2), C. Vila Díaz (2), E. Puigoriol Juvanteny (3), S. Moros Weakner (4), V. Álvarez Torrecillas (4), I. Gallego Anton (8), M.Panadès Tejero (8), M. Zarcero Estevez (5), S. Griñó [...]
